Rivaroxaban Viatris 20 mg, Filmtabletten - 28 Swissmedic Key 69319008 Registration Holder Viatris Pharma GmbH Name Rivaroxaban Viatris 20 mg, Filmtabletten Date of registration 19.10.2023 Introduction of Sequence 19.10.2023 ATC-Classification Rivaroxaban (B01AF01) Revision date WHO WHO-DDD Valid until 18.10.2028 Index Therapeuticus (BSV) Show package size 28 Index Therapeuticus (Swissmedic) 06.03. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680693190085 Medication Code Synthetika Pharmacode Disponibility
Composition rivaroxabanum 20 mg, cellulosum microcristallinum, lactosum monohydricum 40.500 mg, carmellosum natricum conexum, hypromellosum, natrii laurilsulfas, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, E 172 (rubrum), pro compresso obducto corresp. natrium 0.454 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Rivaroxabanum 20 mg
Inactive agents Dose additional_information (Rubrum) Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. E 172 color. Hypromellosum Lactose Monohydrate 40.5 mg Macrogol 3350 Magnesii Stearas Natrii Laurilsulfas Poly(Alcohol Vinylicus) Überzug Pro Compresso Obducto Talcum
Source Data was imported : 08.11.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
